Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambelli

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancerAlessandra Fabi, Elena Giordani, Elena Ricciardi, et al.
Cancers|August 11, 2019
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
JCO Clinical Cancer Informatics|November 6, 2025
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast CancerElena Zazzetti, Saverio D'Amico, Flavia Jacobs, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatmentsCarmine Valenza, Dario Trapani, Sara Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerSergio Marchini, Robert Fruscio, Luca Clivio, et al.
Cancer|October 13, 2005
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantationJacopo Peccatori, Lisbeth Barkholt, Tanner Demirer, et al.
Future Oncology (London, England)|November 29, 2017
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?Alessandra Fabi, Diana Giannarelli, Luca Moscetti, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|March 5, 2017
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signatureFrancesco Moccia, Vittoria Fotia, Richard Tancredi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2023
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future ResearchFabio Conforti, Laura Pala, Tommaso De Pas, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2026
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancerAlessandra Fabi, Elena Giordani, Elena Ricciardi, et al.
Cancers|August 11, 2019
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, et al.
Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.
JCO Clinical Cancer Informatics|November 6, 2025
Longitudinal Synthetic Data Generation by Artificial Intelligence to Accelerate Clinical and Translational Research in Breast CancerElena Zazzetti, Saverio D'Amico, Flavia Jacobs, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2023
Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC): retrospective multicentric analysis of post-progression treatmentsCarmine Valenza, Dario Trapani, Sara Gandini, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2012
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancerSergio Marchini, Robert Fruscio, Luca Clivio, et al.
Cancer|October 13, 2005
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantationJacopo Peccatori, Lisbeth Barkholt, Tanner Demirer, et al.
Future Oncology (London, England)|November 29, 2017
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?Alessandra Fabi, Diana Giannarelli, Luca Moscetti, et al.
Pageof 17